Literature DB >> 24029382

Fusobacterium spp. and colorectal cancer: cause or consequence?

Temitope O Keku1, Amber N McCoy, Andrea M Azcarate-Peril.   

Abstract

Although increasing evidence suggests a relationship between bacterial dysbiosis and colorectal cancer (CRC), few studies have identified specific microbial etiologic factors. Recent studies have implicated overabundance of Fusobacterium in association with colorectal adenomas and cancer. Two articles published in Cell Host & Microbe provide insights into the Fusobacterium-CRC relationship.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029382      PMCID: PMC3836616          DOI: 10.1016/j.tim.2013.08.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  10 in total

1.  Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans.

Authors:  Nina Sanapareddy; Ryan M Legge; Biljana Jovov; Amber McCoy; Lauren Burcal; Felix Araujo-Perez; Thomas A Randall; Joseph Galanko; Andrew Benson; Robert S Sandler; John F Rawls; Zaid Abdo; Anthony A Fodor; Temitope O Keku
Journal:  ISME J       Date:  2012-05-24       Impact factor: 10.302

2.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

Authors:  Mauro Castellarin; René L Warren; J Douglas Freeman; Lisa Dreolini; Martin Krzywinski; Jaclyn Strauss; Rebecca Barnes; Peter Watson; Emma Allen-Vercoe; Richard A Moore; Robert A Holt
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

3.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

4.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Authors:  Mara Roxana Rubinstein; Xiaowei Wang; Wendy Liu; Yujun Hao; Guifang Cai; Yiping W Han
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

5.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors:  Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

6.  Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.

Authors:  Poonam Dharmani; Jaclyn Strauss; Christian Ambrose; Emma Allen-Vercoe; Kris Chadee
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

7.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

8.  Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.

Authors:  Xiang Jun Shen; John F Rawls; Thomas Randall; Lauren Burcal; Caroline N Mpande; Natascha Jenkins; Biljana Jovov; Zaid Abdo; Robert S Sandler; Temitope O Keku
Journal:  Gut Microbes       Date:  2010-05-13

9.  Microbial dysbiosis in colorectal cancer (CRC) patients.

Authors:  Iradj Sobhani; Julien Tap; Françoise Roudot-Thoraval; Jean P Roperch; Sophie Letulle; Philippe Langella; Gérard Corthier; Jeanne Tran Van Nhieu; Jean P Furet
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Fusobacterium is associated with colorectal adenomas.

Authors:  Amber N McCoy; Félix Araújo-Pérez; Andrea Azcárate-Peril; Jen Jen Yeh; Robert S Sandler; Temitope O Keku
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

  10 in total
  23 in total

Review 1.  Gut microbiome and colorectal adenomas.

Authors:  Santosh Dulal; Temitope O Keku
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

2.  Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.

Authors:  Mara Roxana Rubinstein; Jung Eun Baik; Stephen M Lagana; Richard P Han; William J Raab; Debashis Sahoo; Piero Dalerba; Timothy C Wang; Yiping W Han
Journal:  EMBO Rep       Date:  2019-03-04       Impact factor: 8.807

3.  Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma.

Authors:  Hongli Gong; Yi Shi; Xia Zhou; Chunping Wu; Pengyu Cao; Chen Xu; Dongsheng Hou; Yuezhu Wang; Liang Zhou
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

Review 4.  Fusobacterium nucleatum: a commensal-turned pathogen.

Authors:  Yiping W Han
Journal:  Curr Opin Microbiol       Date:  2015-01-08       Impact factor: 7.934

5.  Direct Detection and Quantification of Bacterial Genes Associated with Inflammation in DNA Isolated from Stool.

Authors:  Ramón Gómez-Moreno; Iraida E Robledo; Abel Baerga-Ortiz
Journal:  Adv Microbiol       Date:  2014-11

6.  FusoBase: an online Fusobacterium comparative genomic analysis platform.

Authors:  Mia Yang Ang; Hamed Heydari; Nick S Jakubovics; Mahafizul Imran Mahmud; Avirup Dutta; Wei Yee Wee; Guat Jah Wong; Naresh V R Mutha; Shi Yang Tan; Siew Woh Choo
Journal:  Database (Oxford)       Date:  2014-08-22       Impact factor: 3.451

7.  Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth.

Authors:  Upsornsawan Itthitaetrakool; Porntip Pinlaor; Somchai Pinlaor; Chariya Chomvarin; Rungtiwa Dangtakot; Apisit Chaidee; Chotechana Wilailuckana; Arunnee Sangka; Aroonlug Lulitanond; Puangrat Yongvanit
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

Review 8.  Optimum health and inhibition of cancer progression by microbiome and resveratrol.

Authors:  James Stokes Iii; Sankalp Vinayak; Jazalyn Williams; Shalie Malik; Rajesh Singh; Upender Manne; Taofeek K Owonikoko; Manoj K Mishra
Journal:  Front Biosci (Landmark Ed)       Date:  2021-01-01

Review 9.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29

10.  Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.

Authors:  Hai-Fang Wang; Lin-Fang Li; Song-He Guo; Qiu-Yao Zeng; Fen Ning; Wan-Li Liu; Ge Zhang
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.